Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 3/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.41 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28376500 | 0.99 | CHRM2 (0.45) | CHRM2MAOAMEN1KMT2ATDP1 | |
| SCHEMBL29078899 | 0.97 | MAOA (0.46) | CHRM2MAOAMEN1KMT2ATDP1 | |
| Hydrochloric Acid SCHEMBL28487523 | 0.88 | MEN1 (0.43) | CHRM2MAOAMEN1KMT2ATDP1 | |
| SCHEMBL144038 | 0.86 | CHRM2 (0.58) | CHRM2MAOAMEN1KMT2ATDP1 | |
| SCHEMBL20503705 | 0.85 | CHRM2 (0.50) | CHRM2MAOAMEN1KMT2ATDP1 | |
| Hydrochloric Acid SCHEMBL919007 | 0.85 | CHRM2 (0.56) | CHRM2MAOAMEN1KMT2ATDP1 | |
| SCHEMBL29801013 | 0.84 | CHRM2 (0.45) | CHRM2MAOAMEN1KMT2ATDP1 | |
| SCHEMBL3391140 | 0.83 | CHRM2 (0.35) | CHRM2MAOAMEN1KMT2ASIGMAR1 | |
| SCHEMBL48855 | 0.83 | MAOA (0.58) | CHRM2MAOAMEN1KMT2ATDP1 | |
| SCHEMBL29008123 | 0.82 | MAOA (0.50) | CHRM2MAOAMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4725996-A2 | BINDER COMPOSITIONS FOR THERMOPLASTIC ROAD MARKINGS | Kraton Polymers Nederland B.V. (NL) | 2026-04-15 | — | — | EP | claimed |
| EP-4084942-B1 | POLYMER BLEND | DUPONT POLYMERS INC (US) | 2025-06-11 | — | — | EP | claimed |
| WO-2025084519-A1 | DISPLAY PANEL COMPRISING COLOR COMPOSITE PARTICLES | 엔스펙트라 주식회사 | 2025-04-24 | — | — | WO | claimed |
| US-12258445-B2 | Curable compositions | AGC Multi Material America, Inc. (US) | 2025-03-25 | — | — | US | claimed |
| US-20240182677-A1 | Curable Compositions | AGC Multi Material America, Inc. | 2024-06-06 | — | — | US | claimed |
| US-20240174623-A1 | Build UP Film Curable Compositions | AGC Multi Material America, Inc. | 2024-05-30 | — | — | US | claimed |
| US-20240174802-A1 | Build UP Film Curable Compositions | AGC MULTI MAT AMERICA INC (US) | 2024-05-30 | — | — | US | claimed |
| WO-2023164430-A1 | CURABLE COMPOSITIONS | AGC Multi Material America, Inc. (US) | 2023-08-31 | — | — | WO | claimed |
| US-20230265275-A1 | Curable Compositions | AGC Multi Material America, Inc. | 2023-08-24 | — | — | US | claimed |
| EP-4196441-A2 | MODIFICATION METHOD FOR THE HALLOYSITE MINERAL AND HALLOYSITE MODIFIED VIA MODIFICATION METHOD | Esan Eczacibasi Endustriyel Hammaddeler Sanayi ve Ticaret Anonim Sirketi (TR) | 2023-06-21 | — | — | EP | claimed |
| US-20080286572-A1 | Reinforced Composite Material | ADVANCE COMPOSITES INTERNATIONAL PTY LTD (AU) | 2008-11-20 | — | — | US | claimed |
| US-20080268214-A1 | Decorative safety glass | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-10-30 | — | — | US | claimed |
| US-20080264558-A1 | Decorative safety glass | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-10-30 | — | — | US | claimed |
| WO-2008115568-A1 | HIGH CONTRAST DECORATIVE SHEETS AND LAMINATES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-09-25 | — | — | WO | claimed |
| US-20080233377-A1 | High contrast high strength decorative sheets and laminates | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-09-25 | — | — | US | claimed |
| US-20080233279-A1 | High contrast decorative films and laminates | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-09-25 | — | — | US | claimed |
| US-20080233352-A1 | High contrast decorative sheets and laminates | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-09-25 | — | — | US | claimed |
| WO-2008115567-A1 | HIGH CONTRAST HIGH STRENGTH DECORATIVE SHEETS AND LAMINATES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-09-25 | — | — | WO | claimed |
| US-20080206504-A1 | Decorative Safety Glass | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-08-28 | — | — | US | claimed |
| WO-1990002779-A1 | USE OF FILLERS COATED WITH TRIALKOXYSILANES | NAINTSCH MINERALWERKE GESELLSCHAFT M.B.H. (AT) | 1990-03-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174623-A1 | Build UP Film Curable Compositions | CBX7, CBX4, CBX2 | CHRM2 809/4885MAOA 117/4885MEN1 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.